NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
Explore clinical trials studying Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8. Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 trial results
NCT04771520
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8, +58 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574
- Conditions
- Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Melanoma, +85 more
- Locations
-
- Holy Cross Hospital Fort Lauderdale, Florida, United States
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler Savannah, Georgia, United States
- Hawaii Cancer Care Inc - Waterfront Plaza Honolulu, Hawaii, United States
- Island Urology Honolulu, Hawaii, United States
NCT03918499
- Conditions
- Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, +15 more
- Locations
-
- HonorHealth Research Institute Scottsdale, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- Texas Oncology at Baylor Charles A Sammons Cancer Center Dallas, Texas, United States
Active, Not Recruiting
Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma
NCT05041153
- Conditions
- Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8, +30 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers
NCT04460937
- Conditions
- Adenocarcinoma Of Esophagus, Brain Diseases, Brain Neoplasms, +80 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Northwestern University Chicago, Illinois, United States
- University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
NCT04220827
- Conditions
- Abdominal Neoplasms, Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, +21 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer
NCT04522336
- Conditions
- Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Related conditions
- Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 (8)
- Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 (8)
- Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 (7)
- Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 (7)
- Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 (7)
- Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 (6)
- Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 (6)
- Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 (6)